Stock Region Penny Picks
Stock Region Watchlist: Friday, Oct 16, 2025.
🔥 Your Friday Market Watchlist is Here!
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The information provided in this newsletter is for informational and entertainment purposes only. It should not be considered as financial or investment advice. The stock market is volatile, and you should always do your own research (DYOR) before making any investment decisions. We are not financial advisors, and any opinions expressed are just that—opinions.
What a week it’s been! We’ve seen some major moves and exciting announcements. Let’s break down the news and see what’s on our radar heading into the weekend.
Biotech & Pharma on the Move
This sector was on fire with positive news. Keep these on your screen:
$SBFM (Sunshine Biopharma): They just launched a cholesterol-fighting medicine, Pravastatin. This is a big deal because it’s a widely used drug, and entering this market could be a significant revenue driver for them. Definitely one to watch.
$BIAF (bioAffinity Technologies): Huge news! They received a Notification of Allowance for a U.S. patent on their lung cancer diagnostic algorithm. Patents create a protective moat around a company’s technology, and for a biotech, that’s golden. This could be a major long-term catalyst.
$BMRA (Biomerica): They’ve teamed up with Henry Schein to market their inFoods® IBS test in the U.S. Partnering with a giant like Henry Schein gives them massive distribution and credibility. This could seriously accelerate their U.S. market penetration.
$WHWK (Whitehawk Therapeutics): A collaboration with Tempus to advance biomarker-driven oncology research. These kinds of partnerships are essential for speeding up development and discovery. It shows they are on the right track and attracting the right partners.
$SCNX (SCIENTURE): Their Arbliâ„¢ product just became the first FDA-approved ready-to-use liquid Losartan. First-to-market advantage is always a plus, especially with FDA approval in hand. This makes them a key player in this specific treatment space.
$CTXR (Citius Oncology): They signed an exclusive commercialization agreement with EVERSANA for their LYMPHIRâ„¢ launch, planned for Q4 2025. Locking down a commercialization partner this early is a strong, confident move. It shows they are serious about a successful launch.
Corporate & Financial Updates
Money moves and strategic plays are what we love to see.
$AUUD (Auddia): They have a new corporate overview out and will be presenting at the Main Event conference next week. Presentations like this are often where companies drop exciting news or future guidance. I’d keep an eye on them leading up to October 21st.
$TOVX (Therivaâ„¢ Biologics): They announced a $4.0 million warrant inducement transaction. This brings in fresh cash, which is the lifeblood for biotech companies. It funds their operations and research, extending their runway.
$CSAI (Cloudastructure, Inc.): Announcing a share repurchase program of up to $5 million. This is a classic shareholder-friendly move. It signals that management believes the stock is undervalued and is willing to put company money behind that belief.
$BLNE (Beeline): They’ve expanded their warehouse capacity to $25 million and added two new banking partners. This is pure growth fuel. Expanding capacity and credit lines means they are preparing for a surge in business. Bullish signal right there.
$NMAX (Newsmax): An interesting one here. Newsmax announced a crypto plan for its asset reserves. This is a bold move for a media company and shows they are looking at modern ways to manage their treasury. It puts them in a very forward-thinking category.
Global & Energy Plays
$HTOO (Fusion Fuel Green PLC): They’ve signed a definitive JV agreement for a major industrial decarbonization project in South Africa. Green energy is a hot topic, and expanding into a new market with a significant project like this is a huge step forward for their global ambitions.
Today’s Market Movers & IPOs
$SLGB (Smart Logistics Global Limited): This logistics provider from China IPO’d yesterday. It’s a B2B player focused on industrial raw materials with its own tech. IPOs can be volatile, but it’s worth watching how the market digests this new player in the logistics space.
$FEMY (Femasys): The stock surged over 39% yesterday! The excitement is building around their upcoming presentation at the ASRM 2025 Scientific Congress. When a stock runs this hot into a conference, you know people are expecting good things.
$IVF (InVitro-Stock-Symbol-Placeholder): This stock had a wild ride yesterday, popping on news that the White House is looking to make IVF more accessible, then pulling back. President Trump also commented on slashing costs. With so much political attention, this ticker is going to be highly sensitive to headlines. High risk, high reward, and pure volatility.
That’s a wrap for this week! Keep your lists tight, do your homework, and get ready for another week of action.
Have a great weekend!
Final Disclaimer: All investments carry risk. The tickers mentioned above are for informational purposes and are not a recommendation to buy or sell. Past performance is not indicative of future results. Please consult with a licensed financial professional before making any investment decisions.